Ex vivo fucosylation of stem cells to improve engraftment: WO2004094619

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Opinion on Therapeutic Patents

• Publication date

  2010-08-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/13543776.2010.495124PMID 20518619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• History, Current Results, and Research in Marrow Transplantation

  2015cited by this paper
• Human CD34+ Cells in Experimental Myocardial Infarction: Long-Term Survival, Sustained Functional Improvement, and Mechanism of Action

  2010cited by this paper
• Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing‐Progressive Multiple Sclerosis

  2010cited by this paper
• The HSC niche concept has turned 31

  2010cited by this paper
• Ex vivo fucosylation to improve the engraftment capability and therapeutic potential of human cord blood stem cells.

  2010cited by this paper
• Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.

  2008cited by this paper
• Biological function of fucosylation in cancer biology.

  2007cited by this paper
• Immune reconstitution after unrelated cord blood transplantation.

  2007cited by this paper
• The therapeutic potential of adult neural stem cells.

  2006cited by this paper
• Adult neural stem cells, neurogenic niches, and cellular therapy

  2006cited by this paper
• OTI-010 Osiris Therapeutics/JCR Pharmaceuticals.

  2006cited by this paper
• Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow.

  2005cited by this paper
• Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies.

  2004cited by this paper
• Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow.

  2004influential reference
• Umbilical cord blood transplantation--how, when and for whom?

  2004cited by this paper
• Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

  2004cited by this paper
• Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

  2004cited by this paper
• Unrelated umbilical cord blood transplantation in adult patients.

  2003cited by this paper
• Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis

  2003cited by this paper
• Umbilical cord blood transplantation: current practice and future innovations.

  2003cited by this paper
• PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin.

  2003cited by this paper
• Intravascular Delivery of Neural Stem Cell Lines to Target Intracranial and Extracranial Tumors of Neural and Non-Neural Origin

  2003cited by this paper
• Umbilical cord blood transplantation: current state of the art

  2002cited by this paper
• Double‐chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units

  2002cited by this paper
• Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally.

  2002influential reference
• Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.

  2002cited by this paper
• Selectins: lectins that initiate cell adhesion under flow.

  2002cited by this paper
• Polymorphonuclear Leukocytes from Individuals Carrying the G329A Mutation in the α1,3-Fucosyltransferase VII Gene (FUT7) Roll on E- and P-Selectins

  2002cited by this paper
• Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

  2001cited by this paper
• Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

  2001cited by this paper
• Specialized contributions by alpha(1,3)-fucosyltransferase-IV and FucT-VII during leukocyte rolling in dermal microvessels.

  2000cited by this paper
• Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD‐scid mice

  2000cited by this paper
• Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.

  1999cited by this paper
• Hematopoietic Progenitor Cell Rolling in Bone Marrow Microvessels: Parallel Contributions by Endothelial Selectins and Vascular Cell Adhesion Molecule 1

  1998cited by this paper
• Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay.

  1997influential reference
• Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.

  1996cited by this paper

• Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19

  2021cites this paper
• ABO phenotype-protected reproduction based on human specific α1,2 L-fucosylation as explained by the Bombay type formation.

  2018cites this paper
• ABO phenotype protected reproduction based on human specific 1,2 fucosylations as explained by the Bombay type formation

  2017cites this paper
• ABO phenotype protected reproduction based on specific fucosylations and explained by Bombay type formation.

  2017influential citation
• Spontaneous and therapeutic glycosidic accommodation of host and graft in ABO(H)-incompatible transplantation, a hypothesis.

  2016cites this paper
• ABO phenotype protected reproduction as it is based on specific fucosylations .

  2016cites this paper
• How an ABO-incompatible graft may improve its survival by phenotype-specific glycosylation of the host. A hypothesis.

  2016cites this paper
• Physiological and therapeutic glycosidic accommodation of host and graft in ABO(H)-incompatible transplantation, a hypothesis.

  2016cites this paper
• ABO phenotype protected reproduction as it is based on specif- 1 ic fucosylations. 2

  2016cites this paper
• Alternative Sources of Hematopoietic Stem Cells and Their Clinical Applications

  2013cites this paper
• Stem Cells and Cancer Stem Cells, Volume 1

  2012cites this paper
• Umblical Cord Blood and Alpha-3 Fucosyl Transferase-Treated Haematopoietic Stem Cells for Transplantation

  2012cites this paper
• Alternative donor hematopoietic stem cell transplantation: A role for umbilical cord blood transplantation for hematologic malignancies

  2012cites this paper
• Mesenchymal Stromal Cells and Umbilical Cord Blood Transplantation

  2012cites this paper
• Chimeric proteins comprising the constant region of immunoglobulins for treating hemophilia B (WO2005001025)

  2011cites this paper
• Cell lines expressing mutant FX proteins to generate proteins with reduced rate of fucosylation: WO2010/141478

  2011cites this paper
• Modulation of GDP-fucose level for generating proteins with reduced rate of fucosylation (WO2010141855)

  2011cites this paper
• Transplantation of cord blood stem cells for treating hematologic diseases and strategies to improve engraftment

  2010cites this paper